伊梅格林胺增强了以PDX1为媒介的α-to-β重编程,这种重编程发生在β细胞废除的小岛上
Rei Fujishima1, Tomomi Taguchi1, Naoya Shimizu1
1Department of Endocrinology, Diabetes and Metabolism, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan.
Biochemical and biophysical research communications
|November 2, 2025
概括
在小鼠模型中,Imeglimin增强胰腺α细胞转化为产生胰岛素的β细胞. 这一发现为新的糖尿病再生疗法提供了潜力.
科学领域:
- 内分泌学 在内分泌学.
- 再生医学是一种再生医学.
- 细胞生物学 细胞生物学
背景情况:
- 糖尿病是由胰腺β细胞的胰岛素分泌不足引起的.
- 为糖尿病治疗产生功能性β细胞仍然是一个重大挑战.
- 胰腺α细胞可以通过转录因子,如PDX1.1,被重新编程成产生胰岛素的细胞.
研究的目的:
- 为了研究抗糖尿病药物伊梅格林对α-β细胞重编程的影响.
- 评估伊梅格林在增强功能替代β细胞生成方面的潜力.
主要方法:
- 使用了一种转基因小鼠模型,在阿尔法细胞中表达PDX1.
- 用于评估其对α-β细胞重编程效率的影响.
- 使用aloxan诱导β细胞切除,以评估imeglimin在糖尿病条件下的作用.
主要成果:
- 外源的PDX1表达重新编程了~16.5%的α细胞变成产生胰岛素的细胞.
- 伊梅格林显著提高了重编程效率,提高了27.8% (2周) 和48.7% (4周).
- 伊梅格林在贝塔细胞切除后进一步提高了重编程,达到58.4%,并减少了非功能性重编程细胞.
结论:
- 伊梅格林治疗有效地促进了在PDX1.1存在时的α-β细胞重编程.
- 在糖尿病条件下,伊梅格林可能有助于维持替代β细胞的功能.
- 这项研究表明,伊梅格林在开发糖尿病细胞疗法的潜在作用.
相关概念视频
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
2.1K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
2.1K
Glucagon-like Receptor Agonists
832
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
832
Cell Specific Gene Expression
16.2K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
16.2K
Dipeptidyl Peptidase 4 Inhibitors
574
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
574
Insulin Secretory Vesicles
6.4K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
6.4K


